Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04484974
Other study ID # 20-0048
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 23, 2020
Est. completion date September 19, 2023

Study information

Verified date November 2023
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a within-subjects crossover study that examines subjective appetite, food intake, hormone and metabolic responses to consumption of mid morning snacks of pecan nuts as compared to an iso-caloric amount of tortilla chips. Pecans are high in fat and calories and low in carbohydrate by weight, while tortilla chips are mostly carbohydrate and essentially devoid of fat. These two very different nutrient profiles should elicit different metabolic and biomarker responses. The study aims to determine whether these treatments also elicit different subjective appetite and food intake responses. Participants will be healthy volunteers with overweight and obesity, a population that may be seeking healthy snacking options that are satisfying and satiating.


Description:

This is a randomized, two condition, crossover study in healthy individuals with overweight and obesity examining the effect of a mid-morning snack of pecans vs. a low fat savory snack on appetite, energy expenditure, blood biomarkers of appetite and metabolism and ad libitum food intake at lunch. Twenty-four participants will be enrolled and studied on two test days with at least one week washout in between. On test days, participants will have baseline measures of appetite (by Visual Analogue Scale (VAS)), blood hormones and substrates, and energy expenditure and fuel oxidation (Resting Metabolic Rate (RMR), by indirect calorimetry) taken just prior to consuming a standardized 300 kcal breakfast. VAS measures will be taken at 20, 30, 60, 90 and 120 min following the meal and RMR will be measured for 20 min after eating. A mid-morning snack of either 250 kcal of pecans or lightly salted tortilla chips will be consumed and VAS and blood measures will be taken at 20, 30, 60, 90 and 120 min following the snack and RMR will be measured for 20 min after eating. Participants will be given an ad libitum lunch meal and VAS and blood measures will be taken at 20, 30, 60, 90 and 120 min following the lunch and RMR will be measured for 20 min after eating. Blood will be analyzed for glucose, insulin, free fatty acids, triglycerides, ghrelin, leptin, PYY, and GLP-1. Two hypotheses will be examined: 1. pecans will provoke greater feelings of fullness and reduced hunger after the snack and lunch meal consumption (on either a calorie per calorie or volume basis) as compared to the tortilla chip snack, and 2. the pecan snack will provoke greater responses of satiety hormones compared to tortilla chips. Post-snack and lunch energy expenditure and fat oxidation will also be compared between treatments as an exploratory aim.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date September 19, 2023
Est. primary completion date September 19, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 50 Years
Eligibility Inclusion Criteria: 1. 35 adult men and women 2. all ethnic groups 3. ages 20-50, 4. BMI 27-35, 5. habitually eat breakfast, 6. willing to eat the test snacks and other foods offered, 7. weight stable for the last 6 months 8. willing to consent and adhere to the test procedures and schedule Exclusion Criteria: 1. nut allergies, 2. uncontrolled thyroid disorders, 3. diabetes mellitus, 4. eating disorders, 5. pregnant, or planning to become pregnant during the study, 6. lactating, 7. uncontrolled hypertension, 8. active dieting 9. intensive physical activity training regimen (>300 min/wk exercise), 10. medical history or current medication that may affect study outcomes per study PI discretion 11. consuming pecans on a regular basis 12. unable to lie still with a clear hood over their head for the measurement of energy expenditure

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pecan snack
Under this condition, each participant will consume a mid morning snack of pecans followed by an ad libitum lunch.
Tortilla chip snack
Under this condition, each participant will consume a mid morning snack consisting of an iso-caloric (equal to the pecan snack) snack of tortilla chips followed by an ad libitum lunch.

Locations

Country Name City State
United States University of Colorado Anschutz Health and Wellness Center Aurora Colorado

Sponsors (2)

Lead Sponsor Collaborator
University of Colorado, Denver American Pecan Council

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline (before snack consumption) to 120 minutes in subjective appetite response to pecan or pretzel snack using visual analog assessment Subjective appetite will be assessed using a visual analog scale. Subjective feelings will be rated on a 100 mm horizontal line preceded by the questions: "How hungry are you right now?" and anchored on the left by "not at all hungry" and by "extremely hungry" on the right; Fullness will be queried by "How full do you feel right now?" anchored by "not at all..." and "extremely..."; Desire to eat will be queried by, "How strong is your desire to eat right now?" anchored by anchored by "not at all..." and "extreme...; and prospective consumption will be queried by, "how much food do you think you can you eat right now" with anchors of "not (much) at all" to "extremely/an extreme amount". Baseline (prior to mid-morning snack consumption) to 120 minutes after snack consumption at 20, 30, 60, 90 and 120 minutes following consumption.
Primary Change from baseline (prior to lunch) to 120 minutes in subjective appetite response to lunch meal using visual analog assessment Subjective appetite will be assessed using a visual analog scale. Subjective feelings will be rated on a 100 mm horizontal line preceded by the questions: "How hungry are you right now?" and anchored on the left by "not at all hungry" and by "extremely hungry" on the right; Fullness will be queried by "How full do you feel right now?" anchored by "not at all..." and "extremely..."; Desire to eat will be queried by, "How strong is your desire to eat right now?" anchored by anchored by "not at all..." and "extreme...; and prospective consumption will be queried by, "how much food do you think you can you eat right now" with anchors of "not (much) at all" to "extremely/an extreme amount". Prior to lunch consumption and at 20, 30, 60, 90 and 120 minutes following consumption.
Primary Energy intake response to pecan or pretzel snack using weighed food intake measures Energy intake at ad libitum lunch meal consisting of a variety of different foods offering approximately 1400 of kilocalories of energy having an overall composition of approximately 15% protein, 55% carbohydrate and 30% fat. Twelve ounces of water will be provided as the beverage. Energy intake will be calculated from the weight of each food consumed and the published nutrient composition of the foods. Linear mixed effects model will be used to test the difference in energy intake between two experimental conditions. 30 minutes allowed for completion of the lunch meal
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum glucose following pecan or pretzel snack consumption. Serum glucose by enzymatic method. Baseline (prior to snack) to 120 minutes at intervals of 20, 30, 60, 90 and 120 minutes.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum glucose following lunch consumption. Serum glucose by enzymatic method. Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum insulin following pecan or pretzel snack consumption. Serum insulin by radio-immunoassay. Prior to snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum insulin following lunch consumption. Serum insulin by radio-immunoassay. Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum triglycerides following pecan or pretzel snack consumption. Serum triglycerides by enzymatic assay. Prior to snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum triglycerides following lunch consumption. Serum triglycerides by enzymatic assay. Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum free fatty acids following snack consumption. Serum free fatty acids by enzymatic assay. Prior to mid-morning snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum free fatty acids following lunch consumption. Serum free fatty acids by enzymatic assay. Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum ghrelin following snack consumption. Serum ghrelin by radio-immunoassay Prior to mid-morning snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum ghrelin following lunch consumption. Serum ghrelin by radio-immunoassay Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum peptide YY following snack consumption. Serum peptide YY (PYY) by radio-immunoassay Prior to snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum peptide YY following lunch consumption. Serum peptide YY (PYY) by radio-immunoassay Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change from baseline (prior to snack consumption) to 120 minutes in serum glucagon like peptide-1 following snack consumption. Serum glucagon like peptide-1 (GLP-1) by enzyme immunoassay Prior to snack and at intervals of 20, 30, 60, 90 and 120 minutes after snack consumption.
Primary Change from baseline (prior to lunch consumption) to 120 minutes in serum glucagon like peptide-1 following lunch consumption. Serum glucagon like peptide-1 (GLP-1) by enzyme immunoassay Prior to lunch and at intervals of 20, 30, 60, 90 and 120 minutes after lunch consumption.
Primary Change in serum leptin from baseline to 120 minutes following snack consumption Serum leptin by immunoassay. Baseline (prior to breakfast) and at 120 minutes following mid-morning snack consumption.
Secondary Change from baseline in energy expenditure post snack Post snack resting energy expenditure will be measured using hood indirect calorimetry. Energy expenditure will be measured using standard indirect calorimetry with the ventilated hood technique (Parvo Medics Truemax 2400, Salt Lake City, UT). Resting energy expenditure will be measured for 20 minutes after snack consumption.
Secondary Change from baseline in energy expenditure post lunch Post lunch resting energy expenditure will be measured using hood indirect calorimetry. Energy expenditure will be measured using standard indirect calorimetry with the ventilated hood technique (Parvo Medics Truemax 2400, Salt Lake City, UT). Resting energy expenditure will be measured for 20 minutes after lunch consumption.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03994419 - PErioperAtive CHildhood ObesitY
Recruiting NCT05354245 - Using a Complex Carbohydrate Mixture to Steer Fermentation and Improve Metabolism in Adults With Overweight and Prediabetes (DISTAL) N/A
Completed NCT03602001 - Attentive Eating for Weight Loss N/A
Recruiting NCT06269159 - The Power of 24-hour: Co-designing Intervention Components
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT02996864 - Location-based Smartphone Technology to Guide College Students Healthy Choices Ph II N/A
Completed NCT04647149 - Effects of Early and Delayed Time-restricted Eating in Adults With Overweight and Obesity N/A
Terminated NCT03914066 - A Group-based Treatment of Overweight and Obesity in Primary Care N/A
Completed NCT03685656 - Effect of ANACA3 Slimming Gel on Loss of Abdominal and Thigh Circumferences in Healthy Volunteers N/A
Completed NCT05051579 - A Study of LY3502970 in Participants With Obesity or Overweight With Weight-related Comorbidities Phase 2
Completed NCT04611477 - Effect of Synbiotic 365 on Body Composition in Overweight and Obese Individuals N/A
Active, not recruiting NCT05330247 - Cut Down on Carbohydrate in the Dietary Therapy of Type 2 Diabetes - The Meal Box Study N/A
Completed NCT03599115 - Effects of Inhibitory Control Training in Eating Behaviors N/A
Recruiting NCT06094231 - Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study N/A
Recruiting NCT05938894 - Train Your Brain - Executive Function N/A
Recruiting NCT05987306 - A Self-compassion Focused Intervention for Internalized Weight Bias and Weight Loss N/A
Completed NCT03792685 - Looking for Personalized Nutrition for Obesity/Type 2 Diabetes Mellitus Prevention N/A
Completed NCT05055362 - Effect a Honey, Spice-blended Baked Good Has on Salivary Inflammation Markers in Adults: a Pilot Study N/A
Completed NCT04520256 - Rapid Evaluation of Innovative Intervention Components to Maximize the Health Benefits of Behavioral Obesity Treatment Delivered Online: An Application of Multiphase Optimization Strategy Phase 2/Phase 3
Completed NCT04979234 - A Single Centre, Prospective Feasibility Study to Evaluate the Efficacy of an Endoluminal-suturing Device (Endomina) on Severe Obstructive Sleep Apnea Syndrome N/A